Table 2. Patient disposition Patient... | American Society of Hematology

Table 2.

Patient disposition

Patient disposition (N = 51)	n (%)
Received study drug	51 (100)
Completed study*	3 (6)
Discontinued study	48 (94)
Reason for treatment discontinuation
Disease progression	20 (39)
Lack of efficacy	11 (21)
AE	10 (20)
Death†	4 (8)
Withdrawal by patient	4 (8)
Required for alternative therapy	1 (2)
Other	1 (2)

Patient disposition (N = 51)	n (%)
Received study drug	51 (100)
Completed study*	3 (6)
Discontinued study	48 (94)
Reason for treatment discontinuation
Disease progression	20 (39)
Lack of efficacy	11 (21)
AE	10 (20)
Death†	4 (8)
Withdrawal by patient	4 (8)
Required for alternative therapy	1 (2)
Other	1 (2)

Patients who attended a final follow-up visit 30 d after last study drug dose met the definition for completing study.

Classified as unlikely or definitely not related to study drug by the investigator.